Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials.

Feldman AM, Mann DL, She L, Bristow MR, Maisel AS, McNamara DM, Walsh R, Lee DL, Wos S, Lang I, Wells G, Drazner MH, Schmedtje JF Jr, Pauly DF, Sueta CA, Di Maio M, Kron IL, Velazquez EJ, Lee KL.

Circ Heart Fail. 2013 May;6(3):461-72. doi: 10.1161/CIRCHEARTFAILURE.112.000185.

2.

Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trials.

Feldman AM, She L, McNamara DM, Mann DL, Bristow MR, Maisel AS, Wagner DR, Andersson B, Chiariello L, Hayward CS, Hendry P, Parker JD, Racine N, Selzman CH, Senni M, Stepinska J, Zembala M, Rouleau J, Velazquez EJ, Lee KL.

Cardiology. 2015;130(2):69-81. doi: 10.1159/000368221.

3.

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E; PEACE Investigators..

J Am Coll Cardiol. 2007 Jul 17;50(3):205-14.

4.

The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.

Velazquez EJ, Lee KL, O'Connor CM, Oh JK, Bonow RO, Pohost GM, Feldman AM, Mark DB, Panza JA, Sopko G, Rouleau JL, Jones RH; STICH Investigators..

J Thorac Cardiovasc Surg. 2007 Dec;134(6):1540-7.

5.

Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery.

Fox AA, Nascimben L, Body SC, Collard CD, Mitani AA, Liu KY, Muehlschlegel JD, Shernan SK, Marcantonio ER.

Anesthesiology. 2013 Aug;119(2):284-94. doi: 10.1097/ALN.0b013e318299969c.

6.

Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.

Wrobel K, Stevens SR, Jones RH, Selzman CH, Lamy A, Beaver TM, Djokovic LT, Wang N, Velazquez EJ, Sopko G, Kron IL, DiMaio JM, Michler RE, Lee KL, Yii M, Leng CY, Zembala M, Rouleau JL, Daly RC, Al-Khalidi HR.

Circulation. 2015 Aug 25;132(8):720-30. doi: 10.1161/CIRCULATIONAHA.114.014932.

7.

Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction.

Kukulski T, She L, Racine N, Gradinac S, Panza JA, Velazquez EJ, Chan K, Petrie MC, Lee KL, Pellikka PA, Romanov A, Biernat J, Rouleau JL, Batlle C, Rogowski J, Ferrazzi P, Zembala M, Oh JK; Surgical Treatment for Ischemic Heart Failure Investigators..

J Thorac Cardiovasc Surg. 2015 May;149(5):1312-21. doi: 10.1016/j.jtcvs.2014.09.117.

8.

Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.

Fox AA, Shernan SK, Collard CD, Liu KY, Aranki SF, DeSantis SM, Jarolim P, Body SC.

J Thorac Cardiovasc Surg. 2008 Aug;136(2):452-61. doi: 10.1016/j.jtcvs.2007.12.036.

9.
10.

Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting.

Fox AA, Muehlschlegel JD, Body SC, Shernan SK, Liu KY, Perry TE, Aranki SF, Cook EF, Marcantonio ER, Collard CD.

Anesthesiology. 2010 Apr;112(4):842-51. doi: 10.1097/ALN.0b013e3181d23168.

11.

N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration.

Ballotta A, Ranucci M, Kunkl A, El Baghdady H, Bossone E, Castelvecchio S, Frigiola A, Menicanti L, Di Donato M, Mehta RH.

Am J Cardiol. 2010 Mar 1;105(5):640-4. doi: 10.1016/j.amjcard.2009.10.047.

PMID:
20185010
12.

Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.

Rogers RK, May HT, Anderson JL, Muhlestein JB.

Am Heart J. 2009 Nov;158(5):777-83. doi: 10.1016/j.ahj.2009.09.002.

PMID:
19853697
13.

Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients.

Cabassi A, de Champlain J, Maggiore U, Parenti E, Coghi P, Vicini V, Tedeschi S, Cremaschi E, Binno S, Rocco R, Bonali S, Bianconcini M, Guerra C, Folesani G, Montanari A, Regolisti G, Fiaccadori E.

Int J Cardiol. 2013 Oct 9;168(4):3334-9. doi: 10.1016/j.ijcard.2013.04.039.

PMID:
23623341
14.

Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides.

Romano S, Di Mauro M, Fratini S, Guarracini L, Guarracini F, Poccia G, Penco M.

Cardiovasc Diabetol. 2010 Dec 16;9:89. doi: 10.1186/1475-2840-9-89.

15.

Adiponectin in outpatients with coronary artery disease: independent predictors and relationship with heart failure.

Baldasseroni S, Mannucci E, Orso F, Di Serio C, Pratesi A, Bartoli N, Marella GA, Colombi C, Foschini A, Valoti P, Mossello E, Fumagalli S, Marchionni N, Tarantini F.

Nutr Metab Cardiovasc Dis. 2012 Mar;22(3):292-9. doi: 10.1016/j.numecd.2011.03.012.

PMID:
22032915
16.

Relationship of brain natriuretic peptide concentrations to left ventricular function and adverse outcomes in children with end-stage renal disease undergoing hemodialysis.

Ouali S, Bougmiza I, Abroug S, Omezzine A, Ben Salem H, Neffeti E, Remedi F, Bouslema A, Harabi A, Boughzela E.

Pediatr Cardiol. 2011 Jun;32(5):568-77. doi: 10.1007/s00246-011-9909-8.

PMID:
21336977
17.

Brain natriuretic peptide and acute coronary syndrome.

Mazzone M, Forte P, Portale G, Mancini F, Ursella S, La Sala M, Testa A, Covino M, Pignataro G, Gentiloni Silveri N.

Minerva Med. 2005 Feb;96(1):11-8. Review.

PMID:
15827538
18.

Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.

Ata Y, Turk T, Ay D, Eris C, Demir M, Ari H, Ata F, Yavuz S, Ozyazicioglu A.

Heart Surg Forum. 2009 Aug;12(4):E211-6. doi: 10.1532/HSF98.20091014.

PMID:
19683991
19.

B-type natriuretic peptide as an integrated risk marker in non-ST elevation acute coronary syndromes.

Yamamoto T, Sato N, Yasutake M, Takagi H, Morita N, Akutsu K, Fujii M, Fujita N, Tanaka K, Takano T.

Int J Cardiol. 2006 Aug 10;111(2):224-30.

PMID:
16185779
20.

B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.

van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG, Paulus WJ, Voors AA, Hillege HL.

J Am Coll Cardiol. 2013 Apr 9;61(14):1498-506. doi: 10.1016/j.jacc.2012.12.044.

Items per page

Supplemental Content

Support Center